Hsiang-Fong Kao, MD PhD (@hf_kao) 's Twitter Profile
Hsiang-Fong Kao, MD PhD

@hf_kao

Medical Oncologist in National Taiwan University Cancer Center

ID: 2853182081

calendar_today31-10-2014 07:24:52

7 Tweet

25 Followers

96 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358
Annals of Oncology (@annals_oncology) 's Twitter Profile Photo
Annals of Oncology
@annals_oncology

3 years ago

Nasopharyngeal carcinoma (NPC) is a type of head & neck cancer linked to EBV infection & prevalent in east & southeast Asia. In Annals of Oncology, results of the KEYNOTE-122 randomized, ph III trial of Pembrolizumab vs chemo in platinum-pretreated NPC annalsofoncology.org/article/S0923-…

Clinical Cancer Research (@ccr_aacr) 's Twitter Profile Photo
Clinical Cancer Research
@ccr_aacr

3 years ago

#Lenvatinib plus #eribulin is safe, has manageable side effects and promising efficacy in patients with advanced #leiomyosarcoma and#liposarcoma. Study by Chen et al shows that combining antiangiogenic agents and #chemotherapy is feasible. bit.ly/3GuHviP Tom Wei-Wu Chen

#Lenvatinib plus #eribulin is safe, has manageable side effects and promising efficacy in patients with advanced #leiomyosarcoma and#liposarcoma. Study by Chen et al shows that combining antiangiogenic agents and #chemotherapy is feasible. bit.ly/3GuHviP <a href="/saxotomy/">Tom Wei-Wu Chen</a>
Hsiang-Fong Kao, MD PhD (@hf_kao) 's Twitter Profile Photo
Hsiang-Fong Kao, MD PhD
@hf_kao

2 years ago

An honor to participate in the study! A major breakthrough in NPC treatment!